EGFR and neoplasm: A likely candidate for this factor or mechanism was growth factor/receptor or oncogene de-regulation, as some of the tumours in this study have been found to over-express erbB2, a member of the epidermal growth factor receptor or EGFR family (Gilbertson et al, 1997, 1998).